Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
A prospective randomised controlled trial (RCT) to assess the effect of implementing a trauma nurse co-ordinator (TNC)
ISRCTN ISRCTN76476654
ClinicalTrials.gov identifier
Public title A prospective randomised controlled trial (RCT) to assess the effect of implementing a trauma nurse co-ordinator (TNC)
Scientific title
Acronym N/A
Serial number at source RHC21007
Study hypothesis What are the economic, human and social effects of implementing a trauma nurse co-ordinator?
Lay summary
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Musculoskeletal injury
Participants - inclusion criteria During a one month mapping exercise, 42% of surviving patients had a hospital stay 3 days or less. Therefore 1080 patients will be required to detect a difference of 10% between the study groups in the proportion of the patients discharged within 3 days of admission for a study power of 90% at the 5% two sided significance level. This is assuming a 5% death rate and a recruitment rate of 90%.
Participants - exclusion criteria 1. Refusal to participate
2. Missed patients (information not collected by research assistant)
3. Fractured neck of femur
4. Died in A&E
5. Transfer out of hospital from A&E
Anticipated start date 14/10/1996
Anticipated end date 14/10/1998
Status of trial Completed
Patient information material
Target number of participants 1080
Interventions Eligible patients randomised to 1. TNC care or 2. No TNC care
Primary outcome measure(s) 1. Length of stay - measured in days from admission to discharge.
2. Mortality/Survival - this will be assessed on discharge using the TRISS methodology. The latter is the probability of survival derived by an internationally recognised measure and will be based on the Major Trauma Outcome Study (MTOS) database.
3. Cost - this will quantify the current costs and those incurred in introducing a TNC into a hospital and his/her direct involvement in patient care.
4. Quality of Life - this will be measured using the validated SF36 questionnaire. This form measures health in eight multi-item dimensions, covering functional states, well being and overall evaluation of health. This form has been used, under license, by the Orthopaedic Department in the hospital sine 1992.
5. Satisfaction - this will be measured in both patients and carers using a specially designed questionnaire and will be measured at specific time intervals after discharge.
Secondary outcome measure(s) Not provided at time of registration
Sources of funding NHS Executive North West (UK)
Trial website
Publications
Contact name Mr  Peter  Driscoll
  Address Salford Royal Hospitals NHS Trust
Department of Emergency Medicine
Stott Lane
  City/town Salford
  Zip/Postcode M6 8HD
  Country United Kingdom
  Tel +44 (0)161 787 5372
  Fax +44 (0)161 787 4844
  Email PDriscoll@hope.srht.nwest.nhs.uk
Sponsor NHS R&D Regional Programme Register - Department of Health (UK)
  Address The Department of Health
Richmond House
79 Whitehall
  City/town London
  Zip/Postcode SW1A 2NL
  Country United Kingdom
  Tel +44 (0)20 7307 2622
  Fax +44 (0)20 7307 2623
  Email dhmail@doh.gsi.org.uk
  Sponsor website: http://www.doh.gov.uk
Date applied 23/01/2004
Last edited 11/01/2010
Date ISRCTN assigned 23/01/2004
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central